about
Functional gene-expression analysis shows involvement of schizophrenia-relevant pathways in patients with 22q11 deletion syndromeProton magnetic resonance spectroscopy in 22q11 deletion syndrome.Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.Parkinsonism in phenylketonuria: a consequence of dopamine depletion?Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects.Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion Syndrome.Enhanced maternal origin of the 22q11.2 deletion in velocardiofacial and DiGeorge syndromes.AMPT-induced monoamine depletion in humans: evaluation of two alternative [123I]IBZM SPECT procedures.Internet Safety Issues for Adolescents and Adults with Intellectual Disabilities.Update on the 22q11.2 deletion syndrome and its relevance to schizophrenia.PRODH rs450046 and proline x COMT Val¹⁵⁸ Met interaction effects on intelligence and startle in adults with 22q11 deletion syndrome.Pericardial and bilateral pleural effusion associated with clozapine treatment.COMT Val(158) met genotype and striatal D(2/3) receptor binding in adults with 22q11 deletion syndrome.Correction: Functional Gene-Expression Analysis Shows Involvement of Schizophrenia-Relevant Pathways in Patients with 22q11 Deletion Syndrome.Correction: Proton Magnetic Resonance Spectroscopy in 22q11 Deletion Syndrome.Functional analysis of novel genetic variation in the thyroid hormone activating type 2 deiodinase.Dopamine in high-risk populations: A comparison of subjects with 22q11.2 deletion syndrome and subjects at ultra high-risk for psychosis.Rare Genome-Wide Copy Number Variation and Expression of Schizophrenia in 22q11.2 Deletion Syndrome.Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease.Startle reactivity and prepulse inhibition of the acoustic startle response are modulated by catechol-O-methyl-transferase Val(158) Met polymorphism in adults with 22q11 deletion syndrome.White matter abnormalities in adults with 22q11 deletion syndrome with and without schizophrenia.Serotonergic, noradrenergic and dopaminergic markers are related to cognitive function in adults with 22q11 deletion syndrome.Disrupted dopaminergic neurotransmission in 22q11 deletion syndrome.Non-pharmacological treatment of psychiatric disorders in individuals with 22q11.2 deletion syndrome; a systematic review.Elucidating the diagnostic odyssey of 22q11.2 deletion syndrome.Cardiac sympathetic activity in 22q11.2 deletion syndrome.Unexpected detection of nodular melanoma of the skin on the scalp by I-123 IBZM brain SPECT.Co-occurrence of early-onset Parkinson disease and 22q11.2 deletion syndrome: Potential role for dopamine transporter imaging.Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2.F72. NEUROCOGNITION AND ADAPTIVE FUNCTIONING IN THE 22Q11.2 DELETION SYNDROME MODEL OF SCHIZOPHRENIA.A mouse model of 22q11.2 deletions: Molecular and behavioral signatures of Parkinson's disease and schizophreniaNeuropsychiatric expression and catatonia in 22q11.2 deletion syndrome: An overview and case series22q11.2 Deletion Syndrome-Associated Parkinson's DiseaseGenetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletionA genetic model for multimorbidity in young adultsAge-Related Parkinsonian Signs in Microdeletion 22q11.2.
P50
Q28730977-1C854F8F-92F6-4CE4-BA18-D9E24B921BBAQ33955280-D410436A-18C8-4DCA-82F3-5623B30BA2EBQ34847296-27F469F1-764D-4623-BD55-44840AB709BDQ35220716-4DD99ED1-390A-4E35-A167-FA10596813C4Q35692709-99230F3F-BC87-4F58-94F3-FC9ACA6F206AQ36187243-A2283C5A-D96C-47EA-A1C1-845BCDD78086Q36666974-C822C415-1B6C-4247-A32E-63477CE49703Q36738339-C203B117-8502-4468-B29C-6D6A643A04C7Q38903406-CE12380F-EF57-4ECB-A41C-EAD9E823B234Q39147853-CE2C9F51-E7C9-4EC6-8DFA-52A8390ECDD0Q40841854-7D11E221-C60A-4100-A748-C1E17D465AE3Q44768288-29B71066-2C94-43E4-A068-A81AD54FB9CDQ44782987-0E8D5E95-B8B5-4C6C-8A17-0F147DFFC094Q45767865-0EEC6B29-3597-43DF-B111-97B731FC5CBAQ46560985-DA3386CF-95DB-41EF-B87F-FFA1C7035C44Q46567612-D3FBCC3C-2CD6-42A9-9889-1B5704FEC041Q47570750-77D0786B-00E1-4EDE-99D3-441E21DC8F6BQ47659463-98AFE180-436B-4F65-A16A-D21104FF4464Q47759449-73D32560-98D4-4EBC-9633-90A9913F22E4Q48387730-1877FB27-B82A-4D79-8627-2182C1D48999Q48954898-2A7DFC36-C168-4068-9A4C-0A102E02BB04Q50649964-17A59DCF-AB86-44C1-9770-A4CD619613A8Q51901174-1FAEE374-4080-43DB-8E3D-E4D65B47FBF9Q52315348-B4DF39C6-88BC-454E-BC76-802E312AB597Q52316825-143C53E1-BEA5-49E6-BB95-70E861D3867BQ53127540-8F11BBAC-168D-4DBD-AC3D-423786035D92Q53250932-2FB9DD9D-B7B6-462E-AFE0-2BC7B6547A4EQ53266254-ED1B3874-3B94-4411-939C-03206CADE89DQ55110763-BE0964A5-F71B-4138-ADE9-321738C6CE41Q55295667-B58FFE28-88EB-4F68-8A07-923F85196FECQ58778922-3428CEFD-E848-4FBD-BD3F-0DB3CEA7F953Q61779958-D35F5A94-6A79-43A9-B743-F843C71060B8Q64780272-F43E4290-274E-4C6C-A6D5-A50163754273Q89518831-2F1F9264-B5B9-4E48-B13E-9716FB6E367DQ92296976-0B39579B-9B6D-4A4A-BD81-6E5DC640EB2DQ94582943-ACE7A75B-7BE6-4F5B-BA7F-9EBC918D2365
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Erik Boot
@ast
Erik Boot
@en
Erik Boot
@es
Erik Boot
@nl
Erik Boot
@sl
type
label
Erik Boot
@ast
Erik Boot
@en
Erik Boot
@es
Erik Boot
@nl
Erik Boot
@sl
prefLabel
Erik Boot
@ast
Erik Boot
@en
Erik Boot
@es
Erik Boot
@nl
Erik Boot
@sl
P106
P108
P31
P496
0000-0002-0593-1539